Global Oncology & Cancer Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.  When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

According to our (Global Info Research) latest study, the global Oncology & Cancer Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Oncology & Cancer Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Oncology & Cancer Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology & Cancer Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology & Cancer Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology & Cancer Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology & Cancer Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology & Cancer Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Celgene, Novartis, Bristol-Myers Squibb and Johnson & Johnson, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Oncology & Cancer Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Chemotherapy
    Targeted Therapy
    Immunotherapy (Biologic Therapy)
    Hormonal Therapy
    Others

Market segment by Application
    Blood Cancer
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Others

Major players covered
    Roche
    Celgene
    Novartis
    Bristol-Myers Squibb
    Johnson & Johnson
    Merck & Co.
    AstraZeneca
    Pfizer
    Amgen
    Eli Lilly
    AbbVie
    Takeda
    Astellas
    Ipsen
    Sanofi
    Bayer
    Biogen Idec
    Teva
    Otsuka
    Eisai
    Merck KGaA
    Gilead Sciences

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology & Cancer Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oncology & Cancer Drugs, with price, sales, revenue and global market share of Oncology & Cancer Drugs from 2018 to 2023.
Chapter 3, the Oncology & Cancer Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology & Cancer Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oncology & Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oncology & Cancer Drugs.
Chapter 14 and 15, to describe Oncology & Cancer Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oncology & Cancer Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Oncology & Cancer Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Chemotherapy
        1.3.3 Targeted Therapy
        1.3.4 Immunotherapy (Biologic Therapy)
        1.3.5 Hormonal Therapy
        1.3.6 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Oncology & Cancer Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Blood Cancer
        1.4.3 Breast Cancer
        1.4.4 Gastrointestinal Cancer
        1.4.5 Prostate Cancer
        1.4.6 Respiratory/Lung Cancer
        1.4.7 Others
    1.5 Global Oncology & Cancer Drugs Market Size & Forecast
        1.5.1 Global Oncology & Cancer Drugs Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Oncology & Cancer Drugs Sales Quantity (2018-2029)
        1.5.3 Global Oncology & Cancer Drugs Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Oncology & Cancer Drugs Product and Services
        2.1.4 Roche Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Roche Recent Developments/Updates
    2.2 Celgene
        2.2.1 Celgene Details
        2.2.2 Celgene Major Business
        2.2.3 Celgene Oncology & Cancer Drugs Product and Services
        2.2.4 Celgene Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Celgene Recent Developments/Updates
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Oncology & Cancer Drugs Product and Services
        2.3.4 Novartis Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Novartis Recent Developments/Updates
    2.4 Bristol-Myers Squibb
        2.4.1 Bristol-Myers Squibb Details
        2.4.2 Bristol-Myers Squibb Major Business
        2.4.3 Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
        2.4.4 Bristol-Myers Squibb Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Bristol-Myers Squibb Recent Developments/Updates
    2.5 Johnson & Johnson
        2.5.1 Johnson & Johnson Details
        2.5.2 Johnson & Johnson Major Business
        2.5.3 Johnson & Johnson Oncology & Cancer Drugs Product and Services
        2.5.4 Johnson & Johnson Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Johnson & Johnson Recent Developments/Updates
    2.6 Merck & Co.
        2.6.1 Merck & Co. Details
        2.6.2 Merck & Co. Major Business
        2.6.3 Merck & Co. Oncology & Cancer Drugs Product and Services
        2.6.4 Merck & Co. Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Merck & Co. Recent Developments/Updates
    2.7 AstraZeneca
        2.7.1 AstraZeneca Details
        2.7.2 AstraZeneca Major Business
        2.7.3 AstraZeneca Oncology & Cancer Drugs Product and Services
        2.7.4 AstraZeneca Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 AstraZeneca Recent Developments/Updates
    2.8 Pfizer
        2.8.1 Pfizer Details
        2.8.2 Pfizer Major Business
        2.8.3 Pfizer Oncology & Cancer Drugs Product and Services
        2.8.4 Pfizer Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Pfizer Recent Developments/Updates
    2.9 Amgen
        2.9.1 Amgen Details
        2.9.2 Amgen Major Business
        2.9.3 Amgen Oncology & Cancer Drugs Product and Services
        2.9.4 Amgen Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Amgen Recent Developments/Updates
    2.10 Eli Lilly
        2.10.1 Eli Lilly Details
        2.10.2 Eli Lilly Major Business
        2.10.3 Eli Lilly Oncology & Cancer Drugs Product and Services
        2.10.4 Eli Lilly Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Eli Lilly Recent Developments/Updates
    2.11 AbbVie
        2.11.1 AbbVie Details
        2.11.2 AbbVie Major Business
        2.11.3 AbbVie Oncology & Cancer Drugs Product and Services
        2.11.4 AbbVie Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 AbbVie Recent Developments/Updates
    2.12 Takeda
        2.12.1 Takeda Details
        2.12.2 Takeda Major Business
        2.12.3 Takeda Oncology & Cancer Drugs Product and Services
        2.12.4 Takeda Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Takeda Recent Developments/Updates
    2.13 Astellas
        2.13.1 Astellas Details
        2.13.2 Astellas Major Business
        2.13.3 Astellas Oncology & Cancer Drugs Product and Services
        2.13.4 Astellas Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Astellas Recent Developments/Updates
    2.14 Ipsen
        2.14.1 Ipsen Details
        2.14.2 Ipsen Major Business
        2.14.3 Ipsen Oncology & Cancer Drugs Product and Services
        2.14.4 Ipsen Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Ipsen Recent Developments/Updates
    2.15 Sanofi
        2.15.1 Sanofi Details
        2.15.2 Sanofi Major Business
        2.15.3 Sanofi Oncology & Cancer Drugs Product and Services
        2.15.4 Sanofi Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Sanofi Recent Developments/Updates
    2.16 Bayer
        2.16.1 Bayer Details
        2.16.2 Bayer Major Business
        2.16.3 Bayer Oncology & Cancer Drugs Product and Services
        2.16.4 Bayer Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Bayer Recent Developments/Updates
    2.17 Biogen Idec
        2.17.1 Biogen Idec Details
        2.17.2 Biogen Idec Major Business
        2.17.3 Biogen Idec Oncology & Cancer Drugs Product and Services
        2.17.4 Biogen Idec Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Biogen Idec Recent Developments/Updates
    2.18 Teva
        2.18.1 Teva Details
        2.18.2 Teva Major Business
        2.18.3 Teva Oncology & Cancer Drugs Product and Services
        2.18.4 Teva Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Teva Recent Developments/Updates
    2.19 Otsuka
        2.19.1 Otsuka Details
        2.19.2 Otsuka Major Business
        2.19.3 Otsuka Oncology & Cancer Drugs Product and Services
        2.19.4 Otsuka Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 Otsuka Recent Developments/Updates
    2.20 Eisai
        2.20.1 Eisai Details
        2.20.2 Eisai Major Business
        2.20.3 Eisai Oncology & Cancer Drugs Product and Services
        2.20.4 Eisai Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 Eisai Recent Developments/Updates
    2.21 Merck KGaA
        2.21.1 Merck KGaA Details
        2.21.2 Merck KGaA Major Business
        2.21.3 Merck KGaA Oncology & Cancer Drugs Product and Services
        2.21.4 Merck KGaA Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.21.5 Merck KGaA Recent Developments/Updates
    2.22 Gilead Sciences
        2.22.1 Gilead Sciences Details
        2.22.2 Gilead Sciences Major Business
        2.22.3 Gilead Sciences Oncology & Cancer Drugs Product and Services
        2.22.4 Gilead Sciences Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.22.5 Gilead Sciences Recent Developments/Updates

3 Competitive Environment: Oncology & Cancer Drugs by Manufacturer
    3.1 Global Oncology & Cancer Drugs Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Oncology & Cancer Drugs Revenue by Manufacturer (2018-2023)
    3.3 Global Oncology & Cancer Drugs Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Oncology & Cancer Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Oncology & Cancer Drugs Manufacturer Market Share in 2022
        3.4.2 Top 6 Oncology & Cancer Drugs Manufacturer Market Share in 2022
    3.5 Oncology & Cancer Drugs Market: Overall Company Footprint Analysis
        3.5.1 Oncology & Cancer Drugs Market: Region Footprint
        3.5.2 Oncology & Cancer Drugs Market: Company Product Type Footprint
        3.5.3 Oncology & Cancer Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Oncology & Cancer Drugs Market Size by Region
        4.1.1 Global Oncology & Cancer Drugs Sales Quantity by Region (2018-2029)
        4.1.2 Global Oncology & Cancer Drugs Consumption Value by Region (2018-2029)
        4.1.3 Global Oncology & Cancer Drugs Average Price by Region (2018-2029)
    4.2 North America Oncology & Cancer Drugs Consumption Value (2018-2029)
    4.3 Europe Oncology & Cancer Drugs Consumption Value (2018-2029)
    4.4 Asia-Pacific Oncology & Cancer Drugs Consumption Value (2018-2029)
    4.5 South America Oncology & Cancer Drugs Consumption Value (2018-2029)
    4.6 Middle East and Africa Oncology & Cancer Drugs Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Oncology & Cancer Drugs Sales Quantity by Type (2018-2029)
    5.2 Global Oncology & Cancer Drugs Consumption Value by Type (2018-2029)
    5.3 Global Oncology & Cancer Drugs Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Oncology & Cancer Drugs Sales Quantity by Application (2018-2029)
    6.2 Global Oncology & Cancer Drugs Consumption Value by Application (2018-2029)
    6.3 Global Oncology & Cancer Drugs Average Price by Application (2018-2029)

7 North America
    7.1 North America Oncology & Cancer Drugs Sales Quantity by Type (2018-2029)
    7.2 North America Oncology & Cancer Drugs Sales Quantity by Application (2018-2029)
    7.3 North America Oncology & Cancer Drugs Market Size by Country
        7.3.1 North America Oncology & Cancer Drugs Sales Quantity by Country (2018-2029)
        7.3.2 North America Oncology & Cancer Drugs Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Oncology & Cancer Drugs Sales Quantity by Type (2018-2029)
    8.2 Europe Oncology & Cancer Drugs Sales Quantity by Application (2018-2029)
    8.3 Europe Oncology & Cancer Drugs Market Size by Country
        8.3.1 Europe Oncology & Cancer Drugs Sales Quantity by Country (2018-2029)
        8.3.2 Europe Oncology & Cancer Drugs Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Oncology & Cancer Drugs Market Size by Region
        9.3.1 Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Oncology & Cancer Drugs Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Oncology & Cancer Drugs Sales Quantity by Type (2018-2029)
    10.2 South America Oncology & Cancer Drugs Sales Quantity by Application (2018-2029)
    10.3 South America Oncology & Cancer Drugs Market Size by Country
        10.3.1 South America Oncology & Cancer Drugs Sales Quantity by Country (2018-2029)
        10.3.2 South America Oncology & Cancer Drugs Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Oncology & Cancer Drugs Market Size by Country
        11.3.1 Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Oncology & Cancer Drugs Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Oncology & Cancer Drugs Market Drivers
    12.2 Oncology & Cancer Drugs Market Restraints
    12.3 Oncology & Cancer Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Oncology & Cancer Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Oncology & Cancer Drugs
    13.3 Oncology & Cancer Drugs Production Process
    13.4 Oncology & Cancer Drugs Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Oncology & Cancer Drugs Typical Distributors
    14.3 Oncology & Cancer Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oncology & Cancer Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Oncology & Cancer Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Roche Basic Information, Manufacturing Base and Competitors
    Table 4. Roche Major Business
    Table 5. Roche Oncology & Cancer Drugs Product and Services
    Table 6. Roche Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Roche Recent Developments/Updates
    Table 8. Celgene Basic Information, Manufacturing Base and Competitors
    Table 9. Celgene Major Business
    Table 10. Celgene Oncology & Cancer Drugs Product and Services
    Table 11. Celgene Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Celgene Recent Developments/Updates
    Table 13. Novartis Basic Information, Manufacturing Base and Competitors
    Table 14. Novartis Major Business
    Table 15. Novartis Oncology & Cancer Drugs Product and Services
    Table 16. Novartis Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Novartis Recent Developments/Updates
    Table 18. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 19. Bristol-Myers Squibb Major Business
    Table 20. Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
    Table 21. Bristol-Myers Squibb Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Bristol-Myers Squibb Recent Developments/Updates
    Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 24. Johnson & Johnson Major Business
    Table 25. Johnson & Johnson Oncology & Cancer Drugs Product and Services
    Table 26. Johnson & Johnson Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Johnson & Johnson Recent Developments/Updates
    Table 28. Merck & Co. Basic Information, Manufacturing Base and Competitors
    Table 29. Merck & Co. Major Business
    Table 30. Merck & Co. Oncology & Cancer Drugs Product and Services
    Table 31. Merck & Co. Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Merck & Co. Recent Developments/Updates
    Table 33. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 34. AstraZeneca Major Business
    Table 35. AstraZeneca Oncology & Cancer Drugs Product and Services
    Table 36. AstraZeneca Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. AstraZeneca Recent Developments/Updates
    Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 39. Pfizer Major Business
    Table 40. Pfizer Oncology & Cancer Drugs Product and Services
    Table 41. Pfizer Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Pfizer Recent Developments/Updates
    Table 43. Amgen Basic Information, Manufacturing Base and Competitors
    Table 44. Amgen Major Business
    Table 45. Amgen Oncology & Cancer Drugs Product and Services
    Table 46. Amgen Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Amgen Recent Developments/Updates
    Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 49. Eli Lilly Major Business
    Table 50. Eli Lilly Oncology & Cancer Drugs Product and Services
    Table 51. Eli Lilly Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Eli Lilly Recent Developments/Updates
    Table 53. AbbVie Basic Information, Manufacturing Base and Competitors
    Table 54. AbbVie Major Business
    Table 55. AbbVie Oncology & Cancer Drugs Product and Services
    Table 56. AbbVie Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. AbbVie Recent Developments/Updates
    Table 58. Takeda Basic Information, Manufacturing Base and Competitors
    Table 59. Takeda Major Business
    Table 60. Takeda Oncology & Cancer Drugs Product and Services
    Table 61. Takeda Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Takeda Recent Developments/Updates
    Table 63. Astellas Basic Information, Manufacturing Base and Competitors
    Table 64. Astellas Major Business
    Table 65. Astellas Oncology & Cancer Drugs Product and Services
    Table 66. Astellas Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Astellas Recent Developments/Updates
    Table 68. Ipsen Basic Information, Manufacturing Base and Competitors
    Table 69. Ipsen Major Business
    Table 70. Ipsen Oncology & Cancer Drugs Product and Services
    Table 71. Ipsen Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Ipsen Recent Developments/Updates
    Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 74. Sanofi Major Business
    Table 75. Sanofi Oncology & Cancer Drugs Product and Services
    Table 76. Sanofi Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Sanofi Recent Developments/Updates
    Table 78. Bayer Basic Information, Manufacturing Base and Competitors
    Table 79. Bayer Major Business
    Table 80. Bayer Oncology & Cancer Drugs Product and Services
    Table 81. Bayer Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. Bayer Recent Developments/Updates
    Table 83. Biogen Idec Basic Information, Manufacturing Base and Competitors
    Table 84. Biogen Idec Major Business
    Table 85. Biogen Idec Oncology & Cancer Drugs Product and Services
    Table 86. Biogen Idec Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 87. Biogen Idec Recent Developments/Updates
    Table 88. Teva Basic Information, Manufacturing Base and Competitors
    Table 89. Teva Major Business
    Table 90. Teva Oncology & Cancer Drugs Product and Services
    Table 91. Teva Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 92. Teva Recent Developments/Updates
    Table 93. Otsuka Basic Information, Manufacturing Base and Competitors
    Table 94. Otsuka Major Business
    Table 95. Otsuka Oncology & Cancer Drugs Product and Services
    Table 96. Otsuka Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 97. Otsuka Recent Developments/Updates
    Table 98. Eisai Basic Information, Manufacturing Base and Competitors
    Table 99. Eisai Major Business
    Table 100. Eisai Oncology & Cancer Drugs Product and Services
    Table 101. Eisai Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 102. Eisai Recent Developments/Updates
    Table 103. Merck KGaA Basic Information, Manufacturing Base and Competitors
    Table 104. Merck KGaA Major Business
    Table 105. Merck KGaA Oncology & Cancer Drugs Product and Services
    Table 106. Merck KGaA Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Merck KGaA Recent Developments/Updates
    Table 108. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 109. Gilead Sciences Major Business
    Table 110. Gilead Sciences Oncology & Cancer Drugs Product and Services
    Table 111. Gilead Sciences Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 112. Gilead Sciences Recent Developments/Updates
    Table 113. Global Oncology & Cancer Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 114. Global Oncology & Cancer Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 115. Global Oncology & Cancer Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 116. Market Position of Manufacturers in Oncology & Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 117. Head Office and Oncology & Cancer Drugs Production Site of Key Manufacturer
    Table 118. Oncology & Cancer Drugs Market: Company Product Type Footprint
    Table 119. Oncology & Cancer Drugs Market: Company Product Application Footprint
    Table 120. Oncology & Cancer Drugs New Market Entrants and Barriers to Market Entry
    Table 121. Oncology & Cancer Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 122. Global Oncology & Cancer Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 123. Global Oncology & Cancer Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 124. Global Oncology & Cancer Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 125. Global Oncology & Cancer Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 126. Global Oncology & Cancer Drugs Average Price by Region (2018-2023) & (US$/Unit)
    Table 127. Global Oncology & Cancer Drugs Average Price by Region (2024-2029) & (US$/Unit)
    Table 128. Global Oncology & Cancer Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 129. Global Oncology & Cancer Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 130. Global Oncology & Cancer Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 131. Global Oncology & Cancer Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 132. Global Oncology & Cancer Drugs Average Price by Type (2018-2023) & (US$/Unit)
    Table 133. Global Oncology & Cancer Drugs Average Price by Type (2024-2029) & (US$/Unit)
    Table 134. Global Oncology & Cancer Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 135. Global Oncology & Cancer Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 136. Global Oncology & Cancer Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 137. Global Oncology & Cancer Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 138. Global Oncology & Cancer Drugs Average Price by Application (2018-2023) & (US$/Unit)
    Table 139. Global Oncology & Cancer Drugs Average Price by Application (2024-2029) & (US$/Unit)
    Table 140. North America Oncology & Cancer Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 141. North America Oncology & Cancer Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 142. North America Oncology & Cancer Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 143. North America Oncology & Cancer Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 144. North America Oncology & Cancer Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 145. North America Oncology & Cancer Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 146. North America Oncology & Cancer Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 147. North America Oncology & Cancer Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 148. Europe Oncology & Cancer Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 149. Europe Oncology & Cancer Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 150. Europe Oncology & Cancer Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 151. Europe Oncology & Cancer Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 152. Europe Oncology & Cancer Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 153. Europe Oncology & Cancer Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 154. Europe Oncology & Cancer Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 155. Europe Oncology & Cancer Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 156. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 157. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 158. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 159. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 160. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 161. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 162. Asia-Pacific Oncology & Cancer Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 163. Asia-Pacific Oncology & Cancer Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 164. South America Oncology & Cancer Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 165. South America Oncology & Cancer Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 166. South America Oncology & Cancer Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 167. South America Oncology & Cancer Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 168. South America Oncology & Cancer Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 169. South America Oncology & Cancer Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 170. South America Oncology & Cancer Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 171. South America Oncology & Cancer Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 172. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 173. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 174. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 175. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 176. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 177. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 178. Middle East & Africa Oncology & Cancer Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 179. Middle East & Africa Oncology & Cancer Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 180. Oncology & Cancer Drugs Raw Material
    Table 181. Key Manufacturers of Oncology & Cancer Drugs Raw Materials
    Table 182. Oncology & Cancer Drugs Typical Distributors
    Table 183. Oncology & Cancer Drugs Typical Customers
List of Figures
    Figure 1. Oncology & Cancer Drugs Picture
    Figure 2. Global Oncology & Cancer Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Oncology & Cancer Drugs Consumption Value Market Share by Type in 2022
    Figure 4. Chemotherapy Examples
    Figure 5. Targeted Therapy Examples
    Figure 6. Immunotherapy (Biologic Therapy) Examples
    Figure 7. Hormonal Therapy Examples
    Figure 8. Others Examples
    Figure 9. Global Oncology & Cancer Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 10. Global Oncology & Cancer Drugs Consumption Value Market Share by Application in 2022
    Figure 11. Blood Cancer Examples
    Figure 12. Breast Cancer Examples
    Figure 13. Gastrointestinal Cancer Examples
    Figure 14. Prostate Cancer Examples
    Figure 15. Respiratory/Lung Cancer Examples
    Figure 16. Others Examples
    Figure 17. Global Oncology & Cancer Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 18. Global Oncology & Cancer Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 19. Global Oncology & Cancer Drugs Sales Quantity (2018-2029) & (K Units)
    Figure 20. Global Oncology & Cancer Drugs Average Price (2018-2029) & (US$/Unit)
    Figure 21. Global Oncology & Cancer Drugs Sales Quantity Market Share by Manufacturer in 2022
    Figure 22. Global Oncology & Cancer Drugs Consumption Value Market Share by Manufacturer in 2022
    Figure 23. Producer Shipments of Oncology & Cancer Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 24. Top 3 Oncology & Cancer Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 25. Top 6 Oncology & Cancer Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 26. Global Oncology & Cancer Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 27. Global Oncology & Cancer Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 28. North America Oncology & Cancer Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 29. Europe Oncology & Cancer Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 30. Asia-Pacific Oncology & Cancer Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 31. South America Oncology & Cancer Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 32. Middle East & Africa Oncology & Cancer Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 33. Global Oncology & Cancer Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 34. Global Oncology & Cancer Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 35. Global Oncology & Cancer Drugs Average Price by Type (2018-2029) & (US$/Unit)
    Figure 36. Global Oncology & Cancer Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 37. Global Oncology & Cancer Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 38. Global Oncology & Cancer Drugs Average Price by Application (2018-2029) & (US$/Unit)
    Figure 39. North America Oncology & Cancer Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 40. North America Oncology & Cancer Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 41. North America Oncology & Cancer Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 42. North America Oncology & Cancer Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 43. United States Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. Canada Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. Mexico Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Europe Oncology & Cancer Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 47. Europe Oncology & Cancer Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 48. Europe Oncology & Cancer Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 49. Europe Oncology & Cancer Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 50. Germany Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. France Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 52. United Kingdom Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Russia Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Italy Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Asia-Pacific Oncology & Cancer Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 56. Asia-Pacific Oncology & Cancer Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 57. Asia-Pacific Oncology & Cancer Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 58. Asia-Pacific Oncology & Cancer Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 59. China Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Japan Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. Korea Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 62. India Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Southeast Asia Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Australia Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. South America Oncology & Cancer Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 66. South America Oncology & Cancer Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 67. South America Oncology & Cancer Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 68. South America Oncology & Cancer Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 69. Brazil Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Argentina Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Middle East & Africa Oncology & Cancer Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 72. Middle East & Africa Oncology & Cancer Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 73. Middle East & Africa Oncology & Cancer Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 74. Middle East & Africa Oncology & Cancer Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 75. Turkey Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 76. Egypt Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 77. Saudi Arabia Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 78. South Africa Oncology & Cancer Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 79. Oncology & Cancer Drugs Market Drivers
    Figure 80. Oncology & Cancer Drugs Market Restraints
    Figure 81. Oncology & Cancer Drugs Market Trends
    Figure 82. Porters Five Forces Analysis
    Figure 83. Manufacturing Cost Structure Analysis of Oncology & Cancer Drugs in 2022
    Figure 84. Manufacturing Process Analysis of Oncology & Cancer Drugs
    Figure 85. Oncology & Cancer Drugs Industrial Chain
    Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 87. Direct Channel Pros & Cons
    Figure 88. Indirect Channel Pros & Cons
    Figure 89. Methodology
    Figure 90. Research Process and Data Source

Companies Mentioned

Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences